Data as of Jul 31
| -4.37 / -11.79%|
The 8 analysts offering 12-month price forecasts for Exone Co have a median target of 31.00, with a high estimate of 55.00 and a low estimate of 25.00. The median estimate represents a -5.23% decrease from the last price of 32.71.
The current consensus among 10 polled investment analysts is to Hold stock in Exone Co. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.